All Articles

Beyond impressive Q2 numbers, Bank of Marin’s comeback reveals a masterclass in strategic de-risking and disciplined execution that offers lessons for the sector.

A 30% profit drop at Ohio Valley Banc Corp. highlights a risky strategy: funding rapid loan growth with costly deposits as major credit issues emerge.

FDA clears a pivotal study for Medicus Pharma's SkinJect, a microneedle patch offering new hope for Gorlin Syndrome and a new playbook in biotech strategy.

A Crown corporation's new flyer service is gutting community newspapers, sparking a crisis that pits public service against profit and threatens local democracy.

Rosenberg & Parker's new Financial Institutions Practice, led by Nathan Hummel, signals a major shift in how banks manage risk and capital.

Small biotech Veru Inc. is betting its future on improving blockbuster weight-loss drugs, targeting the hidden cost of muscle loss in a billion-dollar market.

A novel partnership aims to create the first drug for ReNU syndrome, a condition found in 2024, potentially redefining rare disease drug development.

DBGI announced a massive program expansion, but a recent stock split, weak financials, and a fight against market anomalies paint a complex picture.

Catalogic's latest DPX release adds agentless Proxmox protection and deepens cyber resilience, a strategic move to unify data management in a fragmenting IT world.

A new alliance is moving chip design from human-led automation to AI-driven autonomy. Synopsys's agentic AI, on Microsoft's platform and tested by AMD, signals a seismic shift.

Grupo Financiero Atlántida launches NYC-based BancAtlantic, led by John Tonelli, to fill a capital gap in overlooked emerging markets. A strategic masterstroke?

AsymBio breaks ground on a Shanghai R&D center, integrating AI and manufacturing to slash drug development timelines. Is this the end of the CDMO handoff?

C&S Wholesale Grocers' deep price cuts offer shoppers relief, but behind the bargains lies a strategic gambit that could reshape the Midwest's competitive landscape.

With a new CMO and fresh funding, Spero Therapeutics is betting big on its immunology asset SP001. Can Dr. Zack guide it to success in a competitive field?

Hope Bancorp posts impressive Q2 earnings, reversing last year's loss. Strong loan growth and margin expansion set the stage for its strategic MANUBANK deal.

Geospatial leader ProStar appoints Michael Wolff to transition from founder-led innovation to global market dominance in critical infrastructure mapping.

A pool supply giant's move from phone orders to a sophisticated e-commerce platform reveals a critical shift for manufacturers in the digital economy.

A landmark $10B deal between NAVER, NVIDIA, and Brookfield aims to build a sovereign AI factory in South Korea, reshaping the global tech power balance.

Pacira BioSciences de-risks its promising knee osteoarthritis gene therapy by solving the manufacturing puzzle, a key step from lab to market for millions.